EW - Edwards Lifesciences Q1 2022 Earnings Preview
Edwards Lifesciences (NYSE:EW) is scheduled to announce Q1 earnings results on Tuesday, April 26th, after market close. The consensus EPS Estimate is $0.57 (+5.6% Y/Y) and the consensus Revenue Estimate is $1.31B (+7.4% Y/Y). Over the last 2 years, EW has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 17 downward. Revenue estimates have seen 0 upward revisions and 15 downward. Shares of Edwards Lifesciences were down 5% on Jan. 26, as the medical device company's Q4 results missed on both the top and bottom line.
For further details see:
Edwards Lifesciences Q1 2022 Earnings Preview